You searched for viral vector - Page 39 of 53

News and Trends 24 Oct 2022

Syncona to acquire Applied Genetic Technologies Corporation

…AGTC-501, is an investigational recombinant AAV vector-based gene therapy for the treatment of XLRP, a genetic eye disease that causes progressive vision loss and ultimately blindness in men. AGTC-501 recently…

October 24, 2022 - 2 minutesmins - By Jim Cornall

gene therapy cardiac rare disease biomarin dinaqor

News and Trends 7 May 2020

BioMarin Partners Swiss Biotech to Develop Cardiac Gene Therapies

…“We expect a rapid advancement of gene therapies into the clinic over the next several years with a focus on new vectors and potentially organ-specific delivery methods.” Image from Shutterstock…

May 7, 2020 - 2 minutesmins - By Helen Albert

News and Trends 20 Dec 2022

Watch: Valo Therapeutics at Bio-Europe

Valo Therapeutics Oy is a Finnish immunotherapy company developing antigen-coated oncolytic viruses and vaccine vectors as innovative immunotherapy approaches against cancer and infectious disease. The Valo Therapeutics lead platform, PeptiCRAd…

December 20, 2022 - 1 minutemin - By Jim Cornall

News and Trends 18 May 2023

Industry responds to UK science strategy launch

…in genomics, data science and surveillance, including disease vector (such as mosquitoes and ticks) surveillance. The UKHSA also hopes to create a more secure environment, by enhancing understanding of the…

May 18, 2023 - 7 minutesmins - By Jim Cornall

News and Trends 2 Dec 2022

Full-Life Technologies acquiring Focus-X Therapeutics

…peptide radioligands that precisely deliver alpha or beta emitters to break down cancer cell DNA. The platform enables optimization of peptide radioligand vectors for key pharmaceutical attributes such as biodistribution,…

December 2, 2022 - 2 minutesmins - By Jim Cornall

News and Trends 31 Mar 2025

AstraZeneca bets on Asia: a surge of deals in March amid fraud probe

…commercialize a COVID-19 vaccine back in 2021. The vaccine in question was a recombinant adenovirus vector-based vaccine branded KconecaVac, and millions of shots were shipped to mainland China, Pakistan, and…

March 31, 2025 - 7 minutesmins - By Roohi Mariam Peter

News and Trends 21 Feb 2023

New event set to take place in Swedish biotech hub

…Bergström Award for his pioneering work in gene therapy and adeno-associated virus vectors in the field of pharmacology and molecular virology, the Arvid Carlsson Award is destined for Professor Sarah…

February 21, 2023 - 4 minutesmins - By Jim Cornall

News and Trends 4 Nov 2024

Top biotech deals of October 2024

…much demand lately. Roche partnered with Massachusetts-based Dyno Therapeutics to use the latter’s gene delivery platform for gene therapy vectors for neurological diseases. Dyno stands to earn over $1.05 billion…

November 4, 2024 - 8 minutesmins - By Roohi Mariam Peter

Best in Biotech 15 Mar 2023

10 immunotherapy companies making waves in 2023

…vector engineering and induced pluripotent stem cells (iPSC) -derived immunotherapies for the treatment of cancers. IPSCs are skin and blood cells that have been reprogrammed through methods like gene transfer,…

March 15, 2023 - 10 minutesmins - By Roohi Mariam Peter

News and Trends 22 Jun 2017

French Nonprofit Partners with Big American Name to Advance a Gene Therapy for Muscular Dystrophy

…has been developing a micro-dystrophin gene therapy that has proven itself applicable to the disease. As it counts with Europe’s largest cGMP vector manufactory, YposKesi, and one of the world’s…

June 22, 2017 - 3 minutesmins - By Evelyn Warner

Allergan Editas Medicine CRISPR eye disease

News and Trends 15 Mar 2017

Allergan makes a deal with Editas to License CRISPR Programs for Eye Disease

…clinical trial was started in China only last November. Allergan is joining a group of investors that some would argue are purely gambling. Images from vectorfusionart /Shutterstock; Editas Medicine …

March 15, 2017 - 2 minutesmins - By Clara Rodríguez Fernández

News and Trends 4 Nov 2022

Beyond Biotech podcast 21: CanSinoBIO, HTID, Longevity Science Foundation

…Inc. presented clinical trial data for the recombinant COVID-19 vaccine (adenovirus type 5 vector) for inhalation (with the trade name Convidecia Air) at World Vaccine Congress (WVC) Europe recently in…

November 4, 2022 - 2 minutesmins - By Jim Cornall

Knowledge hub

Categories

The top biotech deals of March 2025

The biggest biotech funding rounds in March 2025

Approaches

Therapeutic areas

Join the webinar: AI in antibody discovery - from in silico analysis to AI-enabled data management

Beyond amyloid: The search for the next big thing in Alzheimer’s treatment

R&D

BD

World biotech leaders

Connect with decision-makers and researchers worldwide for collaborative opportunities

Company

Join Us

Subscribe to our newsletter

Advertise with us

The top biotech deals of March 2025

The biggest biotech funding rounds in March 2025

Join the webinar: AI in antibody discovery - from in silico analysis to AI-enabled data management

Beyond amyloid: The search for the next big thing in Alzheimer’s treatment

Connect with decision-makers and researchers worldwide for collaborative opportunities

Subscribe to our newsletter

Advertise with us

Search Results for: viral vector

Syncona to acquire Applied Genetic Technologies Corporation

BioMarin Partners Swiss Biotech to Develop Cardiac Gene Therapies

Watch: Valo Therapeutics at Bio-Europe

Industry responds to UK science strategy launch

Full-Life Technologies acquiring Focus-X Therapeutics

AstraZeneca bets on Asia: a surge of deals in March amid fraud probe

New event set to take place in Swedish biotech hub

Top biotech deals of October 2024

10 immunotherapy companies making waves in 2023

French Nonprofit Partners with Big American Name to Advance a Gene Therapy for Muscular Dystrophy

Allergan makes a deal with Editas to License CRISPR Programs for Eye Disease

Beyond Biotech podcast 21: CanSinoBIO, HTID, Longevity Science Foundation

Subscribe to our newsletter to get the latest biotech news!

The top biotech deals of March 2025

The biggest biotech funding rounds in March 2025

Join the webinar: AI in antibody discovery - from in silico analysis to AI-enabled data management

Beyond amyloid: The search for the next big thing in Alzheimer’s treatment

Connect with decision-makers and researchers worldwide for collaborative opportunities

Subscribe to our newsletter

Advertise with us

The top biotech deals of March 2025

The biggest biotech funding rounds in March 2025

Join the webinar: AI in antibody discovery - from in silico analysis to AI-enabled data management

Beyond amyloid: The search for the next big thing in Alzheimer’s treatment

Connect with decision-makers and researchers worldwide for collaborative opportunities

Subscribe to our newsletter

Advertise with us

Subscribe to our newsletter

Get the latest biotech news directly to your inbox!

Newsletter Signup - Footer

Subscribe to our newsletter to get the latest biotech news!